Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Respiratory Application of a Novel Ultraviolet Light Delivery Device for Patients Infected With COVID-19: A Randomized, Sham-Controlled Study

NCT05166915 is registered in ClinicalTrials.gov with Aytu BioPharma, Inc. as lead sponsor.

NCT NCT05166915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05166915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Respiratory Application of a Novel Ultraviolet Light Delivery Device for Patients Infected With COVID-19: A Randomized, Sham-Controlled Study
Lead sponsor
Aytu BioPharma, Inc.
Phase
Not applicable
Overall status
Withdrawn
Start date
October 31, 2022
Completion date
December 31, 2022
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, covid-19 acute respiratory distress syndrome, covid-19 pneumonia, covid-19 respiratory infection